Search results
Two Biosimilars Approved in Europe for Autoimmune Disorders
Medscape· 5 days agoThe drugs are intended to treat several types of arthritis, psoriasis, COVID-19, and Crohn's...
JD Supra: Update on biosimilars in Canada – March 2024
JD Supra· 4 days agoIn this article, we provide a further update on developments regarding biosimilars in Canada (approvals, pending submissions, litigation, regulatory, and market access) since our March...
AbbVie Inc (ABBV) Q1 2024 Earnings Call Transcript Highlights: Surpassing Expectations with ...
GuruFocus.com via Yahoo Finance· 4 days agoJust wondering if you could maybe frame a little bit for us the opportunity for Skyrizi in UC versus Crohn's disease. I think last time, we heard from J&J, Crohn's represented about $7 billion ...